Power to the Patients

Brandon Li
  • 0.0 (0)
  • LIFE SCIENCES
  • UPDATED WEEKLY
Power to the Patients

Power to the Patients is a LinkedIn Live and podcast series hosted by Power where clinical research leaders across sponsors, sites, CROs, and patient advocacy groups discuss patient centricity in clinical trials. We explore the bottlenecks in today's systems, challenge the status quo and talk about future opportunities for innovation. Looking for a clinical trial? Visit us at www.withpower.com

  1. 31 OCT

    Building a High Recruiting Site in Alzheimer's

    In this episode, Jessica Branning, President of JBran Consulting and former CEO of ClinCloud, shares her  work in creating accessible and patient-focused clinical research sites in the neuropsych space. Jessica’s journey takes us from her early days as a clinical research coordinator to founding ClinCloud, a fully remote-capable site specializing in Alzheimer’s and dementia trials. Tune in as we dive into: How technology like EMR integrations and virtual pre-screening is transforming patient recruitment. The importance of building an ecosystem of support for Alzheimer's patients and their caregivers. Key challenges and learnings in making clinical trials more accessible, including community engagement and education. Whether you’re in clinical research, patient care, or interested in the latest in neuropsychiatry trials, Jessica’s story of building a compassionate, tech-forward site is sure to inspire.

    46 min

  2. 9 OCT

    Why Beckley Psytech is Developing the Next Generation of Psychedelics

    In this episode, Brandon Li sits down with Cosmo Feilding-Mellen, CEO of Beckley Psytech, to explore the groundbreaking work Beckley is doing in the world of psychedelics. Cosmo shares his journey growing up in a family immersed in psychedelic research, co-founding Beckley Psytech, and pushing the boundaries of mental health treatment with next-generation compounds like 5-MeO-DMT. Tune in to discover why Beckley Psytech is focusing on shorter, scalable psychedelic treatments for conditions like treatment-resistant depression and substance use disorders. Cosmo explains how their innovative approach aims to make these therapies more accessible while maintaining high ethical standards, balancing cutting-edge science with compassionate care. Learn about the future of psychedelics as pharmaceutical medicines, and what it takes to develop new treatments in this rapidly evolving field.

    39 min

  3. 3 OCT

    The Mental Health Epidemic in Rural America

    In this episode, we sit down with Jeff Winton, Founder and Chairman of Rural Minds, a nonprofit dedicated to advocating for mental health services in rural America. Jeff shares his deeply personal story of how a family tragedy inspired the creation of Rural Minds and sheds light on the mental health crisis in rural communities, where stigma and lack of access to care create unique challenges. He talks about his career in the biopharmaceutical industry and how it shaped his approach to advocacy. From the isolation of rural life to the growing pressure on fragile healthcare infrastructures, Jeff emphasizes the urgent need for mental health equity and offers insights into how we can better support underserved populations. Listen in to learn more about how Rural Minds is making an impact and why storytelling is central to breaking the silence surrounding mental illness in rural America.

    41 min

  4. 26 SEPT

    Going All In on Psilocybin for Depression

    In this episode, we sit down with Doug Drysdale, CEO of Cybin, to discuss the growing interest in psilocybin as a potential treatment for depression and other mental health conditions. Doug talks candidly about his initial skepticism and how the data convinced him to dive into the world of psychedelic medicine. With decades of experience in drug development, Doug shares why he believes psilocybin represents a new approach to mental health care—one that could provide alternatives to traditional treatments like SSRIs. We explore Cybin's ongoing research, the results from their recent phase two studies, and what’s next as they prepare for phase three trials. Doug also discusses the challenges of working in a field that still faces regulatory hurdles and public stigma, and how his company is navigating these complexities. This conversation is a thoughtful look at the potential of psychedelics in medicine—what's real, what's still uncertain, and what the future might hold for patients seeking new options for managing depression and anxiety. If you're curious about the science behind psilocybin or want to understand where the field of psychedelic medicine is headed, this episode offers an honest and grounded perspective from a leader in the space.

    44 min

  5. 19 SEPT

    Psychedelics and the Future of Anxiety Relief

    In this episode, Dr. Dan Karlin, Chief Medical Officer at MindMed, talks about the potential of psychedelic therapies, especially LSD, to help treat anxiety. He shares his personal journey through psychiatry and addiction medicine, discussing the limitations of traditional treatments and the hope that psychedelics might bring. We dive into MindMed’s research on how LSD could impact generalized anxiety disorder (GAD), with Dr. Karlin explaining how it works and the importance of therapy alongside these treatments. This insightful conversation explores how MindMed is leading the way in developing new solutions for mental health, which could change the way we treat anxiety.

    39 min

  6. 14 JUN

    AliveAndKickn: Raising Awareness about Lynch Syndrome

    Today, we sit down with Robin and Dave Dubin from the AliveAndKickn Foundation, who share their inspiring journey with Lynch Syndrome. Robin explains the genetic intricacies of this hereditary cancer predisposition, emphasizing the crucial role of genetic counseling and the proactive measures taken for their children as previvors.   Dave, a three-time cancer survivor, offers an account of his experiences, shedding light on the motivations behind the foundation's establishment and the significance of patient advocacy. Together, they reveal how personal battles can transform into movements that champion patient-centric approaches in the healthcare landscape.  Topics Discussed:  (00:00:00) Introduction  (00:01:10) Robin’s background  (00:05:07) Screening for Lynch syndrome   (00:07:08) The history of the foundation and what it does   (00:09:10) The biggest challenges in raising awareness for Lynch Syndrome   (00:11:12) What is most effective in educating patients’ families on Lynch Syndrome   (00:12:25) Interacting with larger biopharma and biotech companies pursuing research in this space  (00:15:43) The vaccine for Lynch Syndrome  (00:19:29) Increasing awareness for older patients  (00:22:24) How the foundation tries to educate the clinical community  (00:26:43) The countries the foundation focuses on  (00:28:49) Helping patients communicate with their families  (00:32:46) How people can get involved and support AliveAndKickn  Links:   Robin Beth Dubin   Dave Dubin

    35 min

  7. 7 MAY

    Empowering Patients through Digital Platforms in Clinical Trials with Sasha Sinclair

    In today's episode, Sasha Sinclair discusses the current challenges and emerging solutions shaping the future of patient recruitment and engagement in clinical trials. Sasha has a comprehensive background in clinical operations that allows her to share an informed perspective about how digital strategies and improved education can transform the landscape of clinical research, making it more accessible and inclusive for patients everywhere. She talks about the problem of patients not having access to trials and how to approach it, the new patient recruitment strategies she's excited about, and how the patient's journey affects the decisions made along the way.   Topics Discussed: (00:00:00) Introduction  (00:00:56) Sasha’s background and her current role  (00:02:38) Why patient recruitment is such a struggle currently  (00:03:59) The ceiling on the percentage of providers that could feasibly do research and why it's limited  (00:04:50) How to crack the problem of patients not having access  (00:06:27) What an informal exchange of knowledge is and how it works for the patient  (00:08:13) How Power's platform plugs into the broader ecosystem  (00:10:39) What modern patient recruitment means to Sasha  (00:12:19) The core components Sasha looks for in a modern patient recruitment strategy  (00:14:56) New strategies and approaches Sasha is excited about in patient recruitment strategies  (00:16:54) Piecing together tools for recruitment strategies  (00:20:06) How to think about the incremental investment to be made in recruitment  (00:23:06) The proactive versus reactive approach at the beginning of studies  (00:24:50) Understanding the patient journey and the decisions that get made as a result  (00:26:18) How to think about patient self-advocacy as a sponsor running trials  (00:27:15) How a comprehensive effort from all stakeholders could change the game in research  Links:  Sasha Sinclair

    29 min

  8. 25 JAN

    Integrating Patient Experience in Clinical Trials with Farah Meghji

    How much do you know about the behind-the-scenes process of clinical trials? Our guest today, Farah Meghji, has a unique perspective on the matter through her role at Roche Canada, where patient experience sits at the heart of every stage of solution development. We're thrilled to share her insights on balancing the urgency in clinical trial development with the necessity of embedding patient experiences from the start, transforming the way we think about patient-inclusive culture. Farah also elaborates on how Roche Canada is revolutionizing patient education materials to be more accessible and user-friendly. Topics Discussed: (00:00:00) Introduction (00:00:46) What Farah’s current role entails (00:01:18) The initiatives that Farah’s team takes on  (00:02:13) The patient journey that spans R&Ds through post-marketing (00:03:36) What being the chair of the above-brand patient council entails  (00:05:19) Examples of things implemented to further the patient experience (00:06:41) The differences in patient education communication in Canada (00:07:58) How Farah thinks about the patient experience from the R&D side of things (00:13:18) Analysis of the top barriers for patients as they think about trials (00:16:06) Specific initiatives to address barriers to patients (00:19:04) Trends in where patients are going for information and how they’re using the internet to take control of their situation (00:22:40) The approaches to finding empowered patients today (00:24:20) What Power could do to have the most impact (00:31:08) How Farah hopes to see the industry evolve (00:35:32) Farah’s final thoughts for the audience Links: Farah Meghji

    37 min
See All (15)

About

Power to the Patients is a LinkedIn Live and podcast series hosted by Power where clinical research leaders across sponsors, sites, CROs, and patient advocacy groups discuss patient centricity in clinical trials. We explore the bottlenecks in today's systems, challenge the status quo and talk about future opportunities for innovation. Looking for a clinical trial? Visit us at www.withpower.com

Information

  • Creator
    Brandon Li
  • Years Active
    2023 - 2024
  • Episodes
    15
  • Rating
    Clean
  • Copyright
    © 2023
  • Show Website
    Power to the Patients

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada